Literature DB >> 11435909

Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis.

Y Liu1, B Zhu, L Luo, P Li, D W Paty, M S Cynader.   

Abstract

Increasing evidence shows that oxidative stress plays an important role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), an animal model of the human disease, multiple sclerosis (MS). Heme oxygenase-1 (HO-1) is a heat shock protein induced by oxidative stress. HO-1 metabolizes heme to the antioxidant bilirubin and carbon monoxide, and represents a powerful endogenous defensive mechanism against free radicals in many diseases. However, the role of this important enzyme in EAE remains unknown. In this study, we showed high expression of HO-1 in lesions of EAE, and demonstrated that hemin, an inducer of HO-1, inhibited EAE effectively. In contrast, tin mesoporphyrin, an inhibitor of HO-1, markedly exacerbated EAE. Our results suggest that endogenous HO-1 plays an important protective role in EAE, and that targeted induction of HO-1 overexpression may represent a new therapy for the treatment of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435909     DOI: 10.1097/00001756-200107030-00016

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  29 in total

Review 1.  Immune modulating peptides for the treatment and suppression of multiple sclerosis.

Authors:  Ahmed H Badawi; Teruna J Siahaan
Journal:  Clin Immunol       Date:  2012-06-05       Impact factor: 3.969

2.  Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation.

Authors:  Angelo A Chora; Paulo Fontoura; Andreia Cunha; Teresa F Pais; Sílvia Cardoso; Peggy P Ho; Lowen Y Lee; Raymond A Sobel; Lawrence Steinman; Miguel P Soares
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

Review 3.  Carbon monoxide and the CNS: challenges and achievements.

Authors:  Cláudia S F Queiroga; Alessandro Vercelli; Helena L A Vieira
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 4.  Antioxidants in multiple sclerosis: do they have a role in therapy?

Authors:  Noel G Carlson; John W Rose
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Subbulaxmi Trikudanathan; Alla L Zozulya; Carolina Sandoval-Garcia; Jennifer K Kennedy; Olga Atochina; Thomas Norberg; Bastien Castagner; Peter Seeberger; Zsuzsa Fabry; Donald Harn; Samia J Khoury; Indira Guleria
Journal:  Clin Immunol       Date:  2011-12-30       Impact factor: 3.969

Review 6.  Therapeutic potential of HO-1 in autoimmune diseases.

Authors:  Bao-Zhu Li; Biao Guo; Hai-Yan Zhang; Juan Liu; Sha-Sha Tao; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

7.  Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders.

Authors:  Thomas Stahnke; Christine Stadelmann; Anne Netzler; Wolfgang Brück; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

8.  Effects of heme oxygenase-1 inducer and inhibitor on experimental autoimmune uveoretinitis.

Authors:  Jeong Un Jang; Sook Hee Lee; Chang Uk Choi; Song-Chull Bahk; Hun Taeg Chung; Yun Sik Yang
Journal:  Korean J Ophthalmol       Date:  2007-12

9.  Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Maja Milojkovic; Olivera Dunjic; Dragan Stojanov; Dusica Pavlovic
Journal:  Metab Brain Dis       Date:  2013-04-23       Impact factor: 3.584

10.  Heme oxygenase-1: its therapeutic roles in inflammatory diseases.

Authors:  Hyun-Ock Pae; Hun-Taeg Chung
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.